Stock listing
Oncology Pharma Inc.
Selected listing: ONPH · OTC · USD · US
Oncology Pharma Inc. (OTC:ONPH), Health Technology. Latest release May 7, 2026: Natera Reports First Quarter 2026 Financial Results.
- Ticker
- OTC:ONPH
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Oncology Pharma Inc.
Oncology Pharma Inc. (ticker: ONPH) is a public company operating in the American market, focusing on the development of innovative therapies for cancer treatment. Oncology Pharma is dedicated to advancing its research and product offerings in the oncology sector.
Latest news from Oncology Pharma Inc.
Natera Reports First Quarter 2026 Financial Results
May 7, 2026
Tempus Reports Fourth Quarter and Full Year 2025 Results
February 24, 2026
Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance
February 3, 2026
McKesson Corporation Completes Divestiture of Norwegian Operations
January 30, 2026
Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
July 11, 2022
Research Oncology Pharma Inc.
Oncology Pharma Inc. company profile
View the public company page for Oncology Pharma Inc. on 6ix.
Oncology Pharma Inc. news
Read company news and market updates connected to Oncology Pharma Inc..
Oncology Pharma Inc. investor events
Find investor webinars, events, and replay context for Oncology Pharma Inc..